Loading...

DNA Oyj

DB:24D
Snowflake Description

Proven track record with limited growth.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
24D
DB
€3B
Market Cap
  1. Home
  2. DE
  3. Telecom
Company description

DNA Oyj, together with its subsidiaries, provides mobile communication services primarily in Finland. The last earnings update was 3 days ago. More info.


Add to Portfolio Compare Print
24D Share Price and Events
7 Day Returns
-0.3%
DB:24D
-3.5%
DE Telecom
-0.7%
DE Market
1 Year Returns
17.9%
DB:24D
-4.6%
DE Telecom
-7.6%
DE Market
24D Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
DNA Oyj (24D) -0.3% 0% -1% 17.9% - -
DE Telecom -3.5% -5.6% -4.9% -4.6% -10.6% -0.2%
DE Market -0.7% -0.9% -3.8% -7.6% 8.2% 11.1%
1 Year Return vs Industry and Market
  • 24D outperformed the Telecom industry which returned -4.6% over the past year.
  • 24D outperformed the Market in Germany which returned -7.6% over the past year.
Price Volatility
24D
Industry
5yr Volatility vs Market
Related Companies

24D Value

 Is DNA Oyj undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of DNA Oyj to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for DNA Oyj.

DB:24D Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 9 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 5.4%
Perpetual Growth Rate 10-Year DE Government Bond Rate 0.2%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:24D
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate 0.2%
Equity Risk Premium S&P Global 6.5%
Telecom Unlevered Beta Simply Wall St/ S&P Global 0.35
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.349 (1 + (1- 20%) (23.25%))
0.607
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.8
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.23% + (0.8 * 6.51%)
5.44%

Discounted Cash Flow Calculation for DB:24D using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for DNA Oyj is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

DB:24D DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (EUR, Millions) Source Present Value
Discounted (@ 5.44%)
2020 130.98 Analyst x5 124.23
2021 140.98 Analyst x5 126.82
2022 148.34 Est @ 5.22% 126.56
2023 153.86 Est @ 3.72% 124.50
2024 157.97 Est @ 2.67% 121.24
2025 161.04 Est @ 1.94% 117.22
2026 163.34 Est @ 1.43% 112.76
2027 165.08 Est @ 1.07% 108.09
2028 166.42 Est @ 0.82% 103.35
2029 167.49 Est @ 0.64% 98.65
Present value of next 10 years cash flows €1,163.41
DB:24D DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= €167.49 × (1 + 0.23%) ÷ (5.44% – 0.23%)
€3,223.31
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= €3,223.31 ÷ (1 + 5.44%)10
€1,898.51
DB:24D Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= €1,163.41 + €1,898.51
€3,061.92
Equity Value per Share
(EUR)
= Total value / Shares Outstanding
= €3,061.92 / 132.18
€23.16
DB:24D Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in DB:24D represents 0.99809x of HLSE:DNA
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.99809x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (EUR) x Listing Adjustment Factor
= € 23.16 x 0.99809
€23.12
Value per share (EUR) From above. €23.12
Current discount Discount to share price of €20.92
= -1 x (€20.92 - €23.12) / €23.12
9.5%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price DNA Oyj is available for.
Intrinsic value
10%
Share price is €20.92 vs Future cash flow value of €23.12
Current Discount Checks
For DNA Oyj to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • DNA Oyj's share price is below the future cash flow value, but not at a moderate discount (< 20%).
  • DNA Oyj's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for DNA Oyj's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are DNA Oyj's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:24D PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-06-30) in EUR €0.77
HLSE:DNA Share Price ** HLSE (2019-07-19) in EUR €20.96
Germany Telecom Industry PE Ratio Median Figure of 5 Publicly-Listed Telecom Companies 33.67x
Germany Market PE Ratio Median Figure of 422 Publicly-Listed Companies 19.75x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of DNA Oyj.

DB:24D PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= HLSE:DNA Share Price ÷ EPS (both in EUR)

= 20.96 ÷ 0.77

27.07x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • DNA Oyj is good value based on earnings compared to the DE Telecom industry average.
  • DNA Oyj is overvalued based on earnings compared to the Germany market.
Price based on expected Growth
Does DNA Oyj's expected growth come at a high price?
Raw Data
DB:24D PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 27.07x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 9 Analysts
9.1%per year
Europe Telecom Industry PEG Ratio Median Figure of 35 Publicly-Listed Telecom Companies 1.92x
Germany Market PEG Ratio Median Figure of 270 Publicly-Listed Companies 1.44x

*Line of best fit is calculated by linear regression .

DB:24D PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 27.07x ÷ 9.1%

2.97x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • DNA Oyj is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on DNA Oyj's assets?
Raw Data
DB:24D PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-06-30) in EUR €3.88
HLSE:DNA Share Price * HLSE (2019-07-19) in EUR €20.96
Germany Telecom Industry PB Ratio Median Figure of 7 Publicly-Listed Telecom Companies 1.39x
Germany Market PB Ratio Median Figure of 570 Publicly-Listed Companies 1.71x
DB:24D PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= HLSE:DNA Share Price ÷ Book Value per Share (both in EUR)

= 20.96 ÷ 3.88

5.4x

* Primary Listing of DNA Oyj.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • DNA Oyj is overvalued based on assets compared to the DE Telecom industry average.
X
Value checks
We assess DNA Oyj's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Telecom industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Telecom industry average (and greater than 0)? (1 check)
  5. DNA Oyj has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

24D Future Performance

 How is DNA Oyj expected to perform in the next 1 to 3 years based on estimates from 9 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
9.1%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is DNA Oyj expected to grow at an attractive rate?
  • DNA Oyj's earnings growth is expected to exceed the low risk savings rate of 0.2%.
Growth vs Market Checks
  • DNA Oyj's earnings growth is positive but not above the Germany market average.
  • DNA Oyj's revenue growth is positive but not above the Germany market average.
Annual Growth Rates Comparison
Raw Data
DB:24D Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:24D Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 9 Analysts 9.1%
DB:24D Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 9 Analysts 1.8%
Germany Telecom Industry Earnings Growth Rate Market Cap Weighted Average 23.2%
Germany Telecom Industry Revenue Growth Rate Market Cap Weighted Average 1.9%
Germany Market Earnings Growth Rate Market Cap Weighted Average 12.5%
Germany Market Revenue Growth Rate Market Cap Weighted Average 5.2%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:24D Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 weeks ago) See Below
Future Estimates Average of up to 9 Analyst Estimates (S&P Global) See Below
All numbers in EUR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:24D Future Estimates Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2021-12-31 962 299 130 8
2020-12-31 946 290 121 8
2019-12-31 928 244 110 9
DB:24D Past Financials Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income *
2019-06-30 925 230 102
2019-03-31 918 227 103
2018-12-31 912 208 102
2018-09-30 909 205 103
2018-06-30 901 235 101
2018-03-31 895 232 96
2017-12-31 886 248 93
2017-09-30 877 240 81
2017-06-30 879 222 75
2017-03-31 870 208 68
2016-12-31 859 237 65
2016-09-30 848 255 70

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • DNA Oyj's earnings are expected to grow by 9.1% yearly, however this is not considered high growth (20% yearly).
  • DNA Oyj's revenue is expected to grow by 1.8% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:24D Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 weeks ago) See Below
Future Estimates Average of up to 9 Analyst Estimates (S&P Global) See Below

All data from DNA Oyj Company Filings, last reported 3 weeks ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:24D Future Estimates Data
Date (Data in EUR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2021-12-31 0.99 1.12 0.82 7.00
2020-12-31 0.92 1.02 0.82 7.00
2019-12-31 0.84 0.89 0.77 8.00
DB:24D Past Financials Data
Date (Data in EUR Millions) EPS *
2019-06-30 0.77
2019-03-31 0.78
2018-12-31 0.77
2018-09-30 0.78
2018-06-30 0.76
2018-03-31 0.73
2017-12-31 0.71
2017-09-30 0.62
2017-06-30 0.58
2017-03-31 0.53
2016-12-31 0.51
2016-09-30 0.55

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • DNA Oyj is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).
X
Future performance checks
We assess DNA Oyj's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
DNA Oyj has a total score of 2/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

24D Past Performance

  How has DNA Oyj performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare DNA Oyj's growth in the last year to its industry (Telecom).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • DNA Oyj has delivered over 20% year on year earnings growth in the past 5 years.
  • DNA Oyj's 1-year earnings growth is less than its 5-year average (1.4% vs 31.5%)
  • DNA Oyj's earnings growth has exceeded the DE Telecom industry average in the past year (1.4% vs -45%).
Earnings and Revenue History
DNA Oyj's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from DNA Oyj Company Filings, last reported 3 weeks ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:24D Past Revenue, Cash Flow and Net Income Data
Date (Data in EUR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-06-30 925.35 102.25 40.92
2019-03-31 918.30 103.07 40.92
2018-12-31 911.76 102.23 40.92
2018-09-30 909.46 102.62 37.74
2018-06-30 900.72 100.84 37.74
2018-03-31 895.03 96.32 37.74
2017-12-31 886.09 93.09 37.74
2017-09-30 876.62 81.15 45.14
2017-06-30 879.38 74.84 45.14
2017-03-31 870.34 68.24 45.14
2016-12-31 858.89 65.21 45.14
2016-09-30 847.62 69.52 40.15
2016-06-30 832.48 66.00 40.15
2016-03-31 829.96 59.13 40.15
2015-12-31 828.80 50.05 40.15
2015-09-30 830.64 39.10 41.37
2015-06-30 839.14 14.10 41.37
2015-03-31 834.14 13.70 41.37
2014-12-31 831.54 12.40 41.37
2014-09-30 821.23 15.02 38.44
2014-06-30 797.83 29.52 38.44
2014-03-31 778.63 28.82 38.44
2013-12-31 765.09 27.91 38.44
2013-09-30 762.80 30.64 37.57
2013-06-30 760.60 35.84 37.57
2013-03-31 768.60 39.74 37.57
2012-12-31 769.20 36.14 37.57
2012-09-30 757.53 39.10 33.50

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • DNA Oyj has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • DNA Oyj used its assets more efficiently than the DE Telecom industry average last year based on Return on Assets.
  • DNA Oyj has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess DNA Oyj's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Telecom industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
DNA Oyj has a total score of 4/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

24D Health

 How is DNA Oyj's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up DNA Oyj's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • DNA Oyj's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • DNA Oyj's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of DNA Oyj's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is not covered by short term assets, assets are 0.5x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from DNA Oyj Company Filings, last reported 3 weeks ago.

DB:24D Past Debt and Equity Data
Date (Data in EUR Millions) Total Equity Total Debt Cash & Short Term Investments
2019-06-30 512.89 563.91 36.61
2019-03-31 485.62 413.70 27.39
2018-12-31 604.77 401.93 22.65
2018-09-30 582.74 409.08 19.83
2018-06-30 552.51 442.48 23.58
2018-03-31 483.70 465.89 161.87
2017-12-31 604.36 327.88 23.59
2017-09-30 582.04 371.41 69.44
2017-06-30 563.55 390.01 31.68
2017-03-31 545.46 358.73 44.41
2016-12-31 596.43 367.35 46.24
2016-09-30 541.10 421.50 48.40
2016-06-30 518.70 430.20 17.80
2016-03-31 503.10 428.90 45.50
2015-12-31 524.92 436.79 25.27
2015-09-30 510.60 443.20 12.50
2015-06-30 496.00 463.30 16.60
2015-03-31 486.40 468.70 26.40
2014-12-31 504.14 488.49 10.60
2014-09-30 504.40 495.90 23.40
2014-06-30 508.80 517.50 27.30
2014-03-31 500.20 337.40 26.20
2013-12-31 521.24 350.80 27.06
2013-09-30 516.60 336.80 17.00
2013-06-30 509.50 295.00 7.70
2013-03-31 500.90 290.60 37.20
2012-12-31 527.80 263.93 8.22
2012-09-30 521.40 273.80 7.00
  • DNA Oyj's level of debt (109.9%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (101.7% vs 109.9% today).
  • Debt is well covered by operating cash flow (40.8%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 21.8x coverage).
X
Financial health checks
We assess DNA Oyj's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. DNA Oyj has a total score of 2/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

24D Dividends

 What is DNA Oyj's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
5.25%
Current annual income from DNA Oyj dividends. Estimated to be 5.1% next year.
If you bought €2,000 of DNA Oyj shares you are expected to receive €105 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • DNA Oyj's pays a higher dividend yield than the bottom 25% of dividend payers in Germany (1.48%).
  • DNA Oyj's dividend is above the markets top 25% of dividend payers in Germany (3.92%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:24D Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 9 Analyst Estimates (S&P Global) See Below
Germany Telecom Industry Average Dividend Yield Market Cap Weighted Average of 5 Stocks 5.3%
Germany Market Average Dividend Yield Market Cap Weighted Average of 325 Stocks 3.2%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.5%
Germany Top 25% Dividend Yield 75th Percentile 3.9%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:24D Future Dividends Estimate Data
Date (Data in €) Dividend per Share (annual) Avg. No. Analysts
2021-12-31 1.10 8.00
2020-12-31 1.09 8.00
2019-12-31 1.02 9.00
DB:24D Past Annualized Dividends Data
Date (Data in €) Dividend per share (annual) Avg. Yield (%)
2019-02-01 1.100 5.549
2018-02-02 0.460 2.512
2017-01-31 0.550 4.053

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Whilst dividend payments have been stable, DNA Oyj has been paying a dividend for less than 10 years.
  • Dividend payments have increased, but DNA Oyj only paid a dividend in the past 2 years.
Current Payout to shareholders
What portion of DNA Oyj's earnings are paid to the shareholders as a dividend.
  • Dividends paid are not well covered by earnings (1.1x coverage).
Future Payout to shareholders
  • Dividends after 3 years are not well covered by earnings (0.9x coverage).
X
Income/ dividend checks
We assess DNA Oyj's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can DNA Oyj afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. DNA Oyj has a total score of 2/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

24D Management

 What is the CEO of DNA Oyj's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Jukka Leinonen
COMPENSATION €1,091,000
AGE 57
TENURE AS CEO 5.7 years
CEO Bio

Mr. Jukka Leinonen has been the Chief Executive Officer and President at DNA Ltd. since November 29, 2013. He serves as a Chief Executive Officer, DNA Plc at DNA Welho Oy. Mr. Leinonen serves as the Head of Networks and Technology at TeliaSonera Finland Oyj. Mr. Leinonen served as an Acting Chief Executive Officer at DNA Ltd. since August 30, 2013 until November 28, 2013 and also served as its Vice President of Corporate Business until November 28, 2013. Mr. Leinonen holds Master of Science in Electrical Engineering from Helsinki University of Technology in 1988.

CEO Compensation
  • Jukka's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Jukka's remuneration is lower than average for companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the DNA Oyj management team in years:

10.5
Average Tenure
55
Average Age
  • The average tenure for the DNA Oyj management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Jukka Leinonen

TITLE
President & CEO
COMPENSATION
€1M
AGE
57
TENURE
5.7 yrs

Timo Karppinen

TITLE
Chief Financial Officer
AGE
55
TENURE
6.6 yrs

Tommy Olenius

TITLE
Senior Vice President of Technology
AGE
57
TENURE
10.5 yrs

Janne Aalto

TITLE
Chief Information Officer
AGE
54
TENURE
5.5 yrs

Marja Mäkinen

TITLE
Head of Investor Relations

Asta Rantanen

TITLE
Senior VP of Legal Affairs & Secretary to the Board
AGE
57
TENURE
12.5 yrs

Vilhelmiina Wahlbeck

TITLE
Vice President of Corporate Communications

Marko Rissanen

TITLE
Senior Vice President of Human Resources
AGE
45
TENURE
12.5 yrs

Pekka Väisänen

TITLE
Senior Vice President of Consumer Business
AGE
53
TENURE
10.5 yrs

Jarkko Utriainen

TITLE
Head of Department of New Business
Board of Directors Tenure

Average tenure and age of the DNA Oyj board of directors in years:

5.5
Average Tenure
57
Average Age
  • The tenure for the DNA Oyj board of directors is about average.
Board of Directors

Pertti Korhonen

TITLE
Chairman of the Board
AGE
58
TENURE
2.6 yrs

Kirsi Sormunen

TITLE
Director
AGE
62
TENURE
5.5 yrs

Jukka Ottela

TITLE
Director
AGE
66
TENURE
9.5 yrs

Anu Nissinen

TITLE
Director
AGE
56
TENURE
5.5 yrs

Tero Ojanperä

TITLE
Director
AGE
53
TENURE
5.5 yrs

Ted Roberts

TITLE
Director
TENURE
0.3 yrs

Anna-Maria Ronkainen

TITLE
Director
AGE
53
TENURE
0.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess DNA Oyj's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. DNA Oyj has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

24D News

Simply Wall St News

24D Company Info

Description

DNA Oyj, together with its subsidiaries, provides mobile communication services primarily in Finland. The company operates through two segments, Consumer and Corporate. The Consumer segment offers communication, information, safety, and entertainment services, including mobile phones, tablets, and dongles; mobile phone subscriptions; voice and data services in mobile and fixed networks; broadband services in mobile and fixed networks; data security services; television services, such as connections and channel packages, as well as fixed telephone connections; and entertainment services in cable, terrestrial, and broadband networks. The Corporate segment provides mobile and corporate network solutions; corporate data security services; wholesale and virtual operator services; and communication and data network solutions, including SMS, telecommunication, and voice services, as well as domestic and international tele operator services. This segment also provides Internet of Things, roaming, and value added services. The company’s stores operate in 40 locations. DNA Oyj was incorporated in 1985 and is headquartered in Helsinki, Finland.

Details
Name: DNA Oyj
24D
Exchange: DB
Founded: 1985
€2,770,538,576
132,182,184
Website: http://www.dna.fi
Address: DNA Oyj
Lakkisepantie 21,
Helsinki,
Uusimaa, 00620,
Finland
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
HLSE DNA Ordinary Shares OMX Nordic Exchange Helsinki FI EUR 30. Nov 2016
DB 24D Ordinary Shares Deutsche Boerse AG DE EUR 30. Nov 2016
LSE 0RKI Ordinary Shares London Stock Exchange GB EUR 30. Nov 2016
BATS-CHIXE DNAH Ordinary Shares BATS 'Chi-X Europe' GB EUR 30. Nov 2016
Number of employees
Current staff
Staff numbers
1,648
DNA Oyj employees.
Industry
Integrated Telecommunication Services
Telecom
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/07/22 00:10
End of day share price update: 2019/07/19 00:00
Last estimates confirmation: 2019/07/19
Last earnings filing: 2019/07/19
Last earnings reported: 2019/06/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.